Related Articles
Efficacy of TCH/TEC neoadjuvant chemotherapy for the treatment of HER‑2‑overexpressing breast cancer
Value of the level of methylation of RASSF1A and WIF-1 in tissue and serum in neoadjuvant chemotherapeutic assessment for advanced breast cancer
Phase II study of neoadjuvant anthracycline combined with nanoparticle albumin‑bound paclitaxel for human epidermal growth factor receptor 2‑negative breast cancer
Comparison of adjuvant ED and EC-D regimens in operable breast invasive ductal carcinoma
HMGB1 knockdown increases the radiosensitivity of esophageal squamous cell carcinoma by regulating the expression of molecules involved in DNA repair